Drug Profile
Research programme: synthetic macrocycles - Ensemble Therapeutics/Bristol-Myers Squibb
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb; Ensemble Discovery
- Developer Bristol-Myers Squibb; Ensemble Therapeutics
- Class Macrocyclic compounds; Small molecules
- Mechanism of Action Protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified